Biotechnology is often hailed as the future of cosmetic formulations. Here,, Director and Cosmetic Chemist at the Institute ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

Ravi Narayan Venkatachalam, a U.S.-based biotechnologist at Jeneil Biotech, specializes in fermentation and specialty ...

Colleagues and academics also testified on Kseniia Petrova's behalf, saying she is doing valuable research to advance cures ...

"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be ...

Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

In a time of regulatory and scientific upheaval, stem cells are facing, and creating, new challenges, says regenerative ...

At a time when the mental health crisis in America is pushing clinicians and researchers to rethink traditional trauma care ...

Manav Rachna aims to provide a structure that makes international education accessible and  academically sound.